Showing results (1431-1440 of 6,130) with videos related to
Sort By:
Pageof 613
International Journal of Antimicrobial Agents|May 27, 2023
In vitro activities of ceftazidime-avibactam, ceftolozane-tazobactam, meropenem-vaborbactam and other comparators against Pseudomonas aeruginosa isolates with discrepant resistance to carbapenems: Data from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2012-2021Yu-Lin Lee, Wen-Chien Ko, Po-Ren HsuehInternational Journal of Antimicrobial Agents|February 27, 2026
Development and validation of a predictive model for profiling antibiotic resistance phenotypes of Acinetobacter baumannii strains via clinical MALDI-TOF mass spectra: a multicenter studyQuan Yuan, Su-Ling Liu, Luan Luan, et al.International Journal of Antimicrobial Agents|November 10, 2024
NpmC - a novel A1408 16S rRNA methyltransferase in the gut of humans and animalsBosco R Matamoros, Carlos Serna, Emilia Wedel, et al.International Journal of Antimicrobial Agents|November 24, 2024
Ceftazidime-avibactam (CAZ-AVI) pharmacokinetics in critically ill patients undergoing continuous venovenous hemodiafiltration (CVVHDF)Amaury O'Jeanson, Konstantinos Ioannidis, Elisabet I Nielsen, et al.International Journal of Antimicrobial Agents|November 14, 2024
Developing a human monoclonal antibody combination CRM25 to prevent rabies after exposureCaifeng Long, Wenbo Wang, Jialiang Du, et al.International Journal of Antimicrobial Agents|November 17, 2024
Eliminating the tigecycline resistance RND efflux pump gene cluster tmexCD-toprJ in bacteria using CRISPR/Cas9Lei Xu, Xiaoyu Lu, Yan Li, et al.International Journal of Antimicrobial Agents|November 29, 2024
Toxicokinetic profiling of VRP-034: Evaluating its potential in mitigating polymyxin-B-associated nephrotoxicityKamlesh Vishwakarma, Anmol Bisht, Parveen Kumar, et al.International Journal of Antimicrobial Agents|October 26, 2024
Assessment of lefamulin 20 µg disk versus broth microdilution when tested against common respiratory pathogensYing Cao, Jichao Zhu, Bingshao Liang, et al.International Journal of Antimicrobial Agents|October 19, 2024
Effectiveness of rifampicin combination therapy for orthopaedic implant-related infections: A systematic review and meta-analysisNaomi Kobayashi, Kazuhiko Matsushita, Emi Kamono, et al.International Journal of Antimicrobial Agents|October 25, 2024
Geographic differences in susceptibility profiles of potential non-class B carbapenemase-producing Enterobacterales isolates against ceftazidime-avibactam, meropenem-vaborbactam, colistin, amikacin, gentamicin, and tigecycline: Data from the Antimicrobial Testing Leadership and Surveillance, 2018-2022Shio-Shin Jean, Wen-Chien Ko, I-Min Liu, et al.Pageof 613